trial

California Collaborative Network to Promote Data Driven Care and Improve Outcomes in Early Psychosis

NCTId NCT04007510
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Enrolling By Invitation
Enrollment 1,329 (estimated)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2026-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Enrolling By Invitation
Enrollment
1,329 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2019-09-10
Primary completion
2026-12-30
Eligibility
ALL · 8 Years · 40 Years

Interventions & indications

Drugs
EPI-CAL data networkCommunity DUP Assessment Tool

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
University of California Riverside at C.I. Trials, Inc.-Inland EmpireCollaborator
National Institute of Mental Health (NIMH)Collaborator
Washington University School of MedicineCollaborator

Sites

1 total
Sacramento, United States

Facts & assertions

4 sourced
Enrollment
1,329
Phase
NA
Primary Completion Date
2026-12-30
Status
ENROLLING_BY_INVITATION
relationships
The graph out of here
drug
EPI-CAL data network
drug
Community DUP Assessment Tool
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
National Institute of Mental Health (NIMH)
company
indication
First Episode Psychosis (FEP)
indication
Psychotic Disorders
indication